PT Mitra Keluarga Karyasehat (MIKA) Q3 2025 earnings summary

Executive summary

• Achieved strong revenue and net income growth for the nine months ended September 30, 2025, with net revenue reaching Rp3.98 trillion and net profit at Rp1.08 trillion, driven by expansion in hospital capacity and specialty services.

• Maintained a leading position in Indonesia's hospital sector, focusing on Greater Jakarta and Surabaya, and recognized for operational excellence and patient care.

• Expanded network with new hospital openings, ongoing construction projects, and new subsidiaries, including significant investments in oncology and advanced medical technology.

• Total assets as of September 30, 2025 stood at Rp8.93 trillion, with equity attributable to owners at Rp6.92 trillion.

Financial highlights

• Revenue increased by 10.0% year-over-year to IDR 3.98 trillion for 9M25, with net income rising 15.6% to IDR 1.08 trillion and net margin improving to 27.2%.

• EBITDA grew 13.3% to IDR 1.55 trillion, with EBITDA margin at 37.7%.

• Gross profit for the period was Rp2.19 trillion, up from Rp1.94 trillion year-over-year.

• Basic earnings per share increased 16.7% to 73, and diluted EPS was Rp73.12, up from Rp65.74.

• Cash and cash equivalents rose 80.9% to IDR 1.93 trillion as of September 30, 2025.

Outlook and guidance

• Pipeline includes seven new hospitals with a total of 1,400 additional beds, and 857 beds to be added in existing hospitals by September 2025.

• Ongoing focus on expanding high-intensity specialty areas, comprehensive oncology services, and healthcare services through subsidiaries.

• Continued modernization and renovation of hospital facilities to enhance patient experience.

• No individual revenue stream exceeded 10% of total revenue, indicating diversified income sources.